Back to search

Sweden· SE-20230509000025

Emtricitabin/Tenofovirdisoproxil Orifarm 200 mg/245 mg Filmdragerad tablett

A medicinal product, registered in Sweden by Orifarm AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedEmtricitabin/Tenofovirdisoproxil Orif…ATC—REGISTER NO.SE-20230509000025PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Orifarm AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20230509000025

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a89645ab-6d8f-4e1e-8083-3db3e881f73f
GET /v1/drugs/a89645ab-6d8f-4e1e-8083-3db3e881f73f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20230509000025",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20230509000025",
  "product_doc_link": "https://docetp.mpa.se/LMF/Emtricitabin_Tenofovirdisoproxil%20Orifarm%20200%20mg_245%20mg%20film-coated%20tablet%20IT%20PL_09001bee83a1039b.pdf"
}

See everything about Emtricitabin/Tenofovirdisoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.